Research published at the beginning of April casts serious doubts about the effectiveness of both surgical and cloth masks in preventing the spread of infectious SARS-CoV-2 particles. In an effort to find more ways of slowing the COVID-19 pandemic, researche…
A new study from Cornell University has made a discovery about SARS-CoV-2 that may help researchers develop an appropriate treatment. Five researchers from Cornell University in Ithaca, New York, set out to learn more about the structure and mechanisms relat…
It is hard to imagine a topic more sensitive, and a situation more difficult, than deciding who gets to live and die in the time of a pandemic. Yet this is the reality of the COVID-19 outbreak and the resource shortage it has caused. In particular, the insu…
The current outbreak of infections with a novel type of coronavirus has sparked global anxiety and concern that the virus might spread too far and too fast and cause dramatic harm before health officials find a way to stop it. But what are the realities of th…
As the coronavirus continues to make the news, a host of untruths has surrounded the topic. In this special feature, we address some of these myths and conspiracies. For live updates on the latest developments regarding the novel coronavirus and COVID-19, cl…
I was officially diagnosed with Lupus in May of 2021. I say officially because my symptoms started long before that, I just didn't know it. Lupus is a chronic autoimmune disease that can cause inflammation and pain in different parts of the body. Your immune system is meant to help your body fight infection. But
Pros Has a sturdy, 11-gauge steel build Supports up to 500 pounds Costs less than $100 Cons Only comes with a straight bar Sticks out two feet from the wall We like the Titan Fitness Adjustable Depth Pull-Up Bar because it’s sturdy, bare-bones, and relatively affordable. The mounting is a touch more complicated than doorway-mounted
Duodenal mucosal resurfacing (DMR) — an investigational endoscopic procedure — helped patients maintain weight loss, and in some cases, even lose additional weight, 3 months after discontinuing GLP-1 receptor agonist therapy, initial results of the open-label, multistage REMAIN-1 trial showed. In addition, “the procedure was well tolerated, with only minor, transient TEAEs [treatment-emergent adverse events]